Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin

Recruiting now · Not applicable

Conditions studied: Acne

In brief

To investigate the safety and efficacy of a skincare regimen in individuals with mild to moderate acne and sensitive skin. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4. The main questions this study aims to answer are: 1. To investigate the safety of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 2. To determine the efficacy of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 3. To assess the participants' satisfaction with the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.

Key facts

Study ID

NCT07749469

Run by

USMARI Research & Innovation Centre

People needed

34

Starts

2026-06-01

Expected to finish

2026-12-30

Last updated by the study team

2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthy Malaysian women and men
• Fitzpatrick skin type II-V
• Age above 18 years old
• Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
• Individuals with mild to moderate acne, based on Comprehensive Acne Severity Scale (CASS)

You may not qualify if…

• Pregnant or breastfeeding women, or those planning pregnancy during the study period.
• Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
• Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to topical products.
• Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.
• Individuals with active inflammatory or allergic dermatological conditions affecting the face, such as atopic dermatitis, eczema, or psoriasis, which may compromise skin barrier function or interfere with study assessments.
• Individuals who have undergone cosmetic or dermatological procedures such as -chemical peel, microneedling, or any procedures aimed at improving acne, within 3 months prior to the study.
• Individuals currently taking medical or hormonal treatments that may interfere with study outcomes, including anti-inflammatory agents, corticosteroids, or other medication interfering with study objectives.
• Individuals with known allergy or hypersensitivity to any ingredients found in the product.

Where it is running

• USMARI Research & Innovation Centre — Petaling Jaya, Selangor, Malaysia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.